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Abstract : Our study aimed to clarify specic oxidative stress and glucose metabolic 
disorders in hemodialysis patients, by examining hydrogen peroxide （H2O2）- and 
high glucose-induced oxidative stress, glucose transport and the failure of glycolysis.  
As an in vitro blood cell model of end-stage renal disease （ESRD） in patients 
with diabetes, human monocytic U937 cells of malignant lymphoma origin were 
exposed to high glucose （28.9 mM） for 6 days, with 5 mM H2O2 added on the last 
day.  The generation of intracellular reactive oxygen species （ROS）, glucose levels, 
lactate levels, AMP-activated protein kinase （AMPK） activity and Glut4 levels 
were examined.  Exposure of U937 cells to H2O2 resulted in a signicant increase 
in intracellular ROS generation and glucose levels.  Under high glucose conditions, 
treatment with H2O2 signicantly promoted these actions.  In H2O2-induced U937 
cells, AMPK activity and Glut4 levels were signicantly increased, but lactate and 
pyruvate levels were signicantly decreased.  Thus, exposure of U937 cells to H2O2 
and a high glucose load promoted an increase in intracellular ROS, and exposure 
to H2O2 induced increased glucose transport and high intracellular glucose due to 
reduced glycolytic metabolism.  This suggests that reduced glycolytic metabolism 
might be induced in states of high oxidative stress in hemodialysis patients with 
diabetes.
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Introduction
　Patients with diabetes mellitus （DM） undergoing hemodialysis are exposed to significant 
oxidative stress 1-6）.  We previously reported increased Cu / Zn-superoxide dismutase （SOD） in 
the blood and upregulated Cu / Zn-SOD mRNA in the leukocytes of hemodialysis patients, as 
well as a correlation between leukocyte membrane lipid peroxidation and expression of Cu /
Zn-SOD mRNA in hemodialysis patients ; this causes oxidative stress which may also occur 
due to blood cell contact with the dialysis membrane7, 8）.  Dialysis-associated oxidative stress is 
associated with complications such as arteriosclerosis 9-11）, however few studies have investigated 
the effect of oxidative stress on glucose metabolism in dialysis patients.  Sugar transport increases 
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in response to depletion of the intracellular ATP supply, shifting to other intracellular glucose 
metabolic pathways, such as the polyol pathway from the glycolytic system, hexosamine pathway, 
pentose phosphate pathway, and protein kinase C pathway 12, 13）, however many aspects of this 
shift are not well defined.  Strict control of blood glucose is necessary in dialysis patients to 
improve prognosis and prevent myocardial infarction, cerebral infarction, and lower extremity 
arterial disease 14-17）.  Therefore, given the potential changes in glycolytic metabolism due to the 
influence of dialysis on blood glucose, it is important to investigate the effect of oxidative stress 
on glycolytic metabolism.
　In this in vitro study, we cultured malignant lymphoma-derived U937 cells in a high glucose 
medium to model end-stage renal disease （ESRD） associated with DM.  We then induced 
oxidative stress by adding hydrogen peroxide （H2O2） to these cells and analyzed the effects on 
reactive oxygen species （ROS）, glucose transport, and glucose metabolism.
Methods
Study materials and cell culture
　Human monocytes （U937 cells, EC85011440） were purchased from the European Collection of 
Animal Cell Culture （ECACC, UK）.  The following reagents were also used in the study : H2O2 
（Wako Co., Osaka, Japan）; fetal bovine serum （FBS ; Sigma Aldrich, St. Louis, MO）; penicillin 
G sodium （Invitrogen, Carlsbad, CA）; streptomycin sulfate （Invitrogen）; and 5-（and-6）- 
chloromethyl-2′, 7′-dichlorodihydrofluorescein diacetate （CM-H2DCF-DA ; Molecular Probes, 
Eugene, OR）.  In order to treat the U937 cells with a high glucose load, cells were cultured 
in Roswell Park Memorial Institute medium （RPMI-1640） containing 28.9 mM glucose for 5 
days （high glucose group）, while the normal glucose group consisted of U937 cells cultured 
in standard RPMI-1640 medium containing 11.1 mM D-glucose.  Previous experimental studies 
showed no dead cells due to apoptosis when the mannitol osmotic pressure was adjusted to 
equal the osmotic pressure of the glucose （30 mM）18）.  U937 cells were cultured by routine 
methods with 10％ FBS, 100 units / mL of penicillin G sodium, and 100μg / mL of streptomycin 
sulfate, at 37°C and 5％ CO2.
Drug treatment
　U937 cells in the normal and high glucose groups （two groups each） were cultured for 5 days, 
and each medium was replaced with or without H2O2 （5 mM）, and then cells were incubated 
for 24 h, after that all the parameters were measured.  The cultural experiment was carried out 
under aseptic conditions.
Evaluation of ROS
　CM-H2DCFDA was used to evaluate intracellular ROS formation in U937 cells treated with 
H2O2 （5 mM）.  After cellular uptake, CM-H2DCFDA is first modified to 2′,7′-dichlorofluorescein 
by intracellular esterases, and then by intracellular ROS to create oxidized fluorescent 2′, 
7′-dichlorofluorescein 19）.  After dissolving CM-H2DCFDA with dimethyl sulfoxide, 7μM 
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CM-H2DCFDA was added to the cells （3×106 cells / mL） and incubated for 15 min at 37℃, 
5％ CO2.  After treatment, the cells were washed with heated phosphate-buffered saline. 
Fluorescence intensity was measured on a plate reader （Berthold Technologies, Bad Wildbad, 
Germany） at an excitation wavelength of 488 nm and a measuring wavelength of 525 nm.
Glucose uptake and glycolysis
　1. Intracellular glucose
　Intracellular glucose concentrations in U937 cells after 5 mM H2O2 treatment were measured 
by high performance liquid chromatography with electrochemical detection （HPLC-ECD）, using 
a separation column ACT-gelPAC （φ4.6×150 mm, Act-Science, Tokyo, Japan） and a glucose 
oxidase-stabilized enzyme-immobilized column GO-ENZ （φ4.0×5 mm, Eicom Co., Kyoto, Japan）. 
Endogenous H2O2 and glucose-derived H2O2 were separated with 100 mM phosphate buffer 
solution （pH 6.5） in the mobile phase.
　2. AMP-activated protein kinase （AMPK）
　AMPK was measured with an AMPK Kinase Assay Kit （CycLex, Nagano, Japan）.  Extracted 
samples were added to a microplate coated with AMPK substrate consisting of mouse Insulin 
Receptor substrate-1 （IRS-1） serine 789-peptide, which induced the phosphoric acid reaction. 
After detection using phosphorylated IRS-1 mouse monoclonal antibody and horseradish 
peroxidase-labeled anti-mouse IgG, the sample was stained using tetra-methylbenzidine and 
measured at 450 nm on a plate reader （Berthold Technologies）.  Fluorescence intensity was 
measured for each protein.
　3. Glut4
　Glut4 was measured using an SLC2A4 （Human） ELISA kit （Abnova, Walnut, CA）. 
Extracted samples and Glut4 were treated with specific biotin-conjugated polyclonal antibody 
and avidin-conjugated horseradish peroxidase, and then placed in a microplate.  After incubation, 
tetra-methylbenzidine substrate was added, and the sample was measured at 450 nm.
　4. Intracellular pyruvate
　Intracellular pyruvate concentrations were measured with a Pyruvate Assay Kit （BioVision 
Research Products, Milpitas, CA）.  Extracted samples were mixed with 50μL Reaction Mix 
（Pyruvate Assay Buffer 46μL, Pyruvate Probe 2μL, Enzyme Mix 2μL）, incubated in the 
dark for 30 min, and then measured at 570 nm on a plate reader （Berthold Technologies）.  The 
fluorescence intensity was measured for each protein.
　5. Intracellular lactic acid
　Intracellular lactic acid concentrations were evaluated in a series using an LT-GEL separation 
column （φ4.6×50 mm ; Eicom） and a lactic acid oxidase-immobilized enzyme-immobilized 
column LT-ENZ （φ4.0×5 mm ; Eicom） and measured by HPLC-ECD.  Endogenous H2O2 and 
lactic acid-derived H2O2 were separated using 100 mM phosphate buffer solution containing 
200 mg tetra-n-hexylammonium bromide / L （pH 7.0）.
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Statistical Analysis
　Results are presented as means＋standard error.  Dunnett’s tests were used, and statistical 
significance was set at P＜ 0.05.
Results
Effect of H2O2 and high glucose on intracellular ROS production
　Compared with untreated cells, ROS production was significantly higher （2-fold） in the normal 
and high glucose groups treated with 5 mM H2O2.  Compared with the normal glucose group, 
ROS production in the high glucose group was significantly higher （1.4-fold）, confirming that 
H2O2 increases ROS production （Fig. 1）.
Intracellular glucose uptake （glucose transport mechanism） and glycolysis
　1. Effect of H2O2 and high glucose on intracellular glucose
　Compared with untreated cells, intracellular glucose was significantly higher （8-fold） in H2O2-
treated cells.  Intracellular glucose was 2-fold higher in the high glucose group than in the 
normal group （P＜0.05 ; Fig. 2a）, thus validating the H2O2-associated increase in intracellular 
glucose.
　2. Effect of H2O2 and high glucose on AMPK production
　AMPK production was significantly higher （1.3-fold） in H2O2-treated cells than in untreated 
cells, however there were no significant differences between the normal and high glucose groups 
（Fig. 2b）.
　3. Effect of H2O2 and high glucose on Glut4 production
　Compared with untreated cells, Glut4 production was significantly higher （1.5-fold） in cells 
from the normal glucose group treated with 5 mM H2O2.  Glut4 production tended to be higher 
Fig. 1.  Effect of hydrogen peroxide （H2O2） and high glucose on 
intracellular reactive oxygen species （ROS） production. 
U937 cells were cultured for 6 days in RPMI-1640 medium 
containing either 11.1 mM D-glucose （Control） or 28.9 mM 
glucose （High glucose）. For the last 24 h, 5 mM H2O2 was 
added to the control group （5 mM H2O2） and the high 
glucose group （High glucose＋5 mM H2O2）. ＊P＜ 0.05 vs. 
Control ; #P＜ 0.05 vs. 5 mM H2O2 ; ▼ P＜ 0.05 vs. High 
glucose.
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in cells treated with 5 mM H2O2, but the change was not significant.  Comparison of the normal 
and high glucose groups revealed no significant changes （Fig. 2c）.
　4.  Effect of H2O2 and high glucose on intracellular pyruvic acid
　Treatment with 5 mM H2O2 significantly reduced intracellular pyruvic acid concentrations in 
cells from both the normal and high glucose groups, compared to untreated cells.  There was no 
significant difference between groups （Fig. 2d）.
　5.  Effect of H2O2 and high glucose on intracellular lactic acid
　Compared with untreated cells, the amount of intracellular lactic acid was significantly reduced 
in cells of the normal and high glucose groups treated with 5 mM H2O2.  Intracellular lactic acid 
Fig. 2.
（a） Effect of hydrogen peroxide （H2O2） and high glucose on intracellular glucose. U937 cells were cultured for 6 
days in RPMI-1640 medium containing either 11.1 mM D-glucose （Control） or 28.9 mM glucose （High glucose）. 
For the last 24 h, 5 mM H2O2 was added to the control group （5 mM H2O2） and the high glucose group （High 
glucose＋ 5 mM H2O2）. ＊P＜ 0.05 vs. Control ; #P＜ 0.05 vs. 5 mM H2O2 ; ▼ P＜ 0.05 vs. High glucose.
（b） Effect of hydrogen peroxide （H2O2） and high glucose on AMP-activated protein kinase （AMPK） production. 
U937 cells were cultured for 6 days in RPMI-1640 medium containing either 11.1 mM D-glucose （Control） or 
28.9 mM glucose （High glucose）. For the last 24 h, 5 mM H2O2 was added to the control group （5 mM H2O2） 
and the high glucose group （High glucose＋5 mM H2O2）. ＊P＜ 0.05 vs. Control ; ▼ P＜ 0.05 vs. High glucose.
（c） Effect of hydrogen peroxide （H2O2） and high glucose on Glut4 production. U937 cells were cultured for 6 days 
in RPMI-1640 medium containing either 11.1 mM D-glucose （Control） or 28.9 mM glucose （High glucose）. For 
the last 24 h, 5 mM H2O2 was added to the control group （5 mM H2O2） and the high glucose group （High 
glucose＋ 5 mM H2O2）. ＊P＜ 0.05 vs. Control.
（d） Effect of hydrogen peroxide （H2O2） and high glucose on intracellular pyruvic acid concentration. U937 cells were 
cultured for 6 days in RPMI-1640 medium containing either 11.1 mM D-glucose （Control） or 28.9 mM glucose 
（High glucose）. For the last 24 h, 5 mM H2O2 was added to the control group （5 mM H2O2） and the high 
glucose group （High glucose＋ 5 mM H2O2）. ＊P＜ 0.05 vs. Control ; ▼ P＜ 0.05 vs. High glucose.
（e） Effect of hydrogen peroxide （H2O2） and high glucose on intracellular lactic acid concentration. U937 cells were 
cultured for 6 days in RPMI-1640 medium containing either 11.1 mM D-glucose （Control） or 28.9 mM glucose 
（High glucose）. For the last 24 h, 5 mM H2O2 was added to the control group （5 mM H2O2） and the high 
glucose group （High glucose＋ 5 mM H2O2）. ＊P＜ 0.05 vs. Control ; ▼ P＜ 0.05 vs. High glucose.
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was 1.5-fold higher than the control in the high glucose group （P＜ 0.05 ; Fig. 2e）.
Discussion
　This in vitro study using U937 cells revealed that intracellular ROS production was 2-fold 
higher after H2O2 treatment, whereas high glucose treatment caused a 1.4-fold increase in 
intracellular ROS, compared to cells treated with normal glucose levels.  Previously, Sakai and 
colleagues 20） cultured human and mouse pancreatic β cells in a high glucose medium （30 mM 
glucose） for 4 days, and found that intracellular ROS production was 4 times higher than in 
cells cultured with 5 mM glucose.  In this study, increased ROS production due to H2O2 was 
augmented by a high glucose load.  Malignant lymphoma-derived U937 cells provide an in vitro 
model of blood cells for DM-associated hemodialysis, raising the possibility that high oxidative 
stress during treatment is worsened in patients with high blood glucose.  This in vitro study 
also proves the importance of strict blood glucose control in order to reduce oxidative stress in 
hemodialysis patients with various complications such as arteriosclerosis 9-11）.
　AMPK is activated when intracellular ATP levels decrease ; the enzyme phosphorylates 
members of the acetyl-CoA carboxylase metabolic pathway 21） and mammalian target of 
rapamycin 22）.  Adjustment of these enzyme activities and the activity of transcription factors 23） 
and cofactors 24） modulates intracellular energy metabolism.  Glut4 is a glucose transporter 
belonging to class I of the Glut family and mediates activation of AMPK and insulin.  Glut4 
promotes transcription and translocation to the plasma membrane, and is also involved in 
promoting glucose uptake.  Horie et al treated rat cardiomyocytes with H2O2 and measured the 
time- and concentration-dependent effects.  Their study showed that a long duration and high 
concentration of H2O2 increased the time required for Glut4 to travel to the cell membrane. 
Delayed Glut4 transport to the cell membrane in AMPK-deficient cells treated with 100μM 
H2O2 （25 vs. 15 min for control） demonstrated the importance of AMPK in Glut4 translocation 
to the cell membrane after H2O2 treatment 25）.  In our study, AMPK was also significantly 
higher （1.3-fold） in cells treated with 5 mM H2O2 for 24 h, while Glut4 was approximately 1.5-
fold higher.  Thus, reduction of either enzyme of glycolytic metabolism reduces intracellular 
ATP.  Furthermore, inhibition of glycolytic metabolism is suspected to inhibit activation of 
glyceraldehyde-3-phosphate dehydrogenase （GAPDH） due to H2O2 load 20, 26）.  We also 
demonstrated that production of lactic acid was suppressed by approximately 70％, whereas 
intracellular glucose increased 8-fold after H2O2 exposure.  Decreased glycolytic metabolism due 
to H2O2 was studied by Sakai et al 20）, who treated mouse pancreatic β cells with 50μM H2O2 
for 30 min and found an approximate 50％ reduction in pyruvic acid, whereas the amount of 
lactic acid remained unchanged.  In contrast, Colussi et al 26） treated U937 cells with 1 mM H2O2 
for 1 h and found that intracellular glucose consumption was 97％, whereas lactic acid production 
was suppressed by 96％.  Our study also observed these reductions, unlike the study by Sakai 
et al 20） which found no such changes.  This discrepancy may be due to differences in cell type, 
H2O2 concentration, or duration of administration.  Our study and that of Colussi et al 26） used 
U937 cells, but in well-differentiated cancer cells such as these, even under oxygenated conditions, 
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lactic acid is generated by translocation of lactate dehydrogenase from pyruvic acid produced 
by glycolysis, in what is known as the Warburg effect 27-29）.  However, if glycolytic metabolism is 
strongly suppressed by H2O2, inhibition of lactic acid production is stronger in cancer cells, such 
as U937 cells with their initially high production of lactic acid, compared with other cells.
　Mitochondria-derived ROS production increases under high glucose conditions, and then, 
resulting in inhibition of the glycolytic metabolic enzyme, GADPH.  Additionally, ROS cause 
DNA damage, leading to activation of poly （ADP-ribose） polymerase12）.  After culturing mouse 
pancreatic β cells in 25 mM glucose for 2 days, Sakai and colleagues found that GADPH 
activity was reduced by 36％ compared with cells incubated in 5 mM glucose 20）.  In addition, Du 
et al 13） cultured bovine endothelial cells in 30 mM glucose for 2 days and found that GADPH 
activity was reduced by 66％ compared with cells treated with 5 mM glucose.  In these studies, 
GADPH activation was reduced by a high glucose load, but reduced activation of GADPH 
usually leads to a reduction in intracellular ATP.  However, in our study, despite the increase 
in intracellular ROS production due to high glucose, the amounts of pyruvic acid and lactic 
acid were not reduced, suggesting no ATP reduction-dependent increase in AMPK or Glut4. 
Glycolysis downstream of pyruvic acid is maintained, as is intracellular ATP.  The type of ROS 
produced might be different under conditions of high glucose load and hydrogen peroxide load, 
or it might be the unique property of cancer cells.  Advanced glycation end products （AGE） 
can serve as an indicator for changes in GADPH activation due to high glucose load.  High 
glucose induces various intracellular glucose pathways, including the glycolytic system by reducing 
GADPH activity via mitochondria-derived ROS production, activation of the hexosamine 
pathway, activation of protein kinase C, increased production of AGE, and activation of the 
polyol pathway 12）.  We previously reported an increase of AGE associated with a high glucose 
load 30）, indicating the possibility of reduced GAPDH activation.
　As an in vitro blood cell model of DM-associated ESRD, this study has a number of 
limitations.  Firstly, our use of malignant lymphoma-derived cancer cells as the study material, 
and secondly, replacing the mechanical stress of contact between blood cells and the dialysis 
membrane with an H2O2 load.  A third limitation of the study is the inability to consider 
changes in glucose metabolism and glucose transport mechanisms due to the change in H2O2 
concentration.  Because blood cells come into contact with the hemodialysis membrane during 
dialysis treatment, the use of monocytic line-derived cells is a valid in vitro model of blood cells 
during hemodialysis, but there is the possibility of metabolic differences, despite the absence of 
the Warburg effect 27-29）.  These results do not mean that mechanical stress influences ROS and 
glycolytic metabolism.  However, despite these limitations, this model can serve as a useful in 
vitro screening tool for DM-associated ESRD.
　In conclusion, this study demonstrated an increase of intracellular ROS due to H2O2 and high 
glucose load, and indicated an increase in glucose transport with reduced glycolytic metabolism 
due to H2O2.  Reduced glycolytic metabolism might be induced in states of high oxidative stress 
in hemodialysis patients with DM.
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